A recent episode of the 99% Invisible podcast discussed the fascinating history of orphan drugs. Orphan drugs treat rare diseases that affect so few patients that commercial production doesn’t make financial sense for pharmaceutical companies. However, when a television producer with a rare disease got involved, the issue went viral and lead to reform. The 30-minute podcast is worth the listen, or you can opt for the written article; both are available here.
Listen: Podcast on The Fascinating History of Orphan Drugs
Learn how drugs that no pharmaceutical company wanted to make evolved into extremely lucrative products subsidized by the government.